Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

750
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

(Poly)phenol profiles of plant-based diets assessed through dietary intake and urinary biomarkers.

Food & function·2026
Same author

Rational Design of Small-Molecule Stabilizers of Human Fumarylacetoacetate Hydrolase for the Treatment of Tyrosinemia Type I.

Journal of medicinal chemistry·2026
Same author

Aminolevulinate inhibition of human coproporphyrinogen oxidase clarifies coproporphyrin III accumulation in porphyrias.

Bioscience reports·2026
Same author

In Vitro Skin Models as Non-Animal Methods for Dermal Drug Development and Safety Assessment.

Pharmaceutics·2025
Same author

Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review.

International journal of molecular sciences·2025
Same author

Correction to "Benchtop Proton NMR Spectroscopy for High-Throughput Lipoprotein Quantification in Human Serum and Plasma".

Analytical chemistry·2025

Related Experiment Video

Updated: Apr 24, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.1K

Biological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A

Gary Sánchez-Gordón1,2,3, Elena Plans-Beriso1,4, Cristina Barahona-López1,4

  • 1Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Instituto de Salud Carlos III Madrid Spain.

Health Science Reports
|April 23, 2026
PubMed
Summary

This scoping review identifies chronic inflammation biomarker signatures using data reduction methods. It aims to map existing literature for early disease detection and understanding inflammation causes.

Keywords:
biological markerscluster analysisdata reduction methodsinflammationinflammation signaturesprincipal component analysis

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

39.9K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

25.4K

Related Experiment Videos

Last Updated: Apr 24, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.1K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

39.9K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

25.4K

Area of Science:

  • Biomedical Science
  • Epidemiology
  • Biomarker Discovery

Background:

  • Chronic inflammation is a key driver of numerous chronic diseases.
  • Accurate measurement of chronic inflammation is challenging due to biomarker variability.
  • Joint analysis of inflammatory biomarkers may reveal specific signatures for chronic inflammation.

Purpose of the Study:

  • To systematically map the literature on chronic inflammation biomarker signatures.
  • To identify signatures identified using data reduction methods in adults.
  • To highlight knowledge gaps in the field of inflammation biomarker research.

Main Methods:

  • Adherence to Joanna Briggs Institute methodology and PRISMA-ScR guidelines.
  • Comprehensive electronic searches in Medline and Embase databases up to October 2023.
  • Inclusion of systematic reviews and primary research analyzing blood, urine, or saliva biomarkers, excluding acute conditions.

Main Results:

  • A PRISMA flowchart will summarize study findings.
  • Interactive visual maps will display identified inflammatory signatures.
  • Categorization of signatures by study design, data reduction method, and population.

Conclusions:

  • This review offers a comprehensive overview of inflammation biomarker signatures.
  • It identifies knowledge gaps in using data reduction methods for inflammation biomarker analysis.
  • Findings will be publicly accessible to advance research.